HLA-E and Miyoshi myopathy: Treatment of MM cells with CX-5461 in the presence of a highly specific ATR kinase inhibitor (ATRi-AZD6738/Ceralasertib) resulted in the absence of HLA-E upregulation in both SKO-007(J3) and RPMI-8226 cells.